Notable Reporting: Pain Therapeutics Inc (NASDAQ:PTIE)

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz
Notable Reporting: Pain Therapeutics Inc (NASDAQ TIE) Institutional Investor Sentiment Is 0.82Notable-Reporting-Pain-Therapeutics-Inc-NASDAQ-PTIE-Institutional-Investor-Sentiment-Is-0-82.jpg

Shares Outstanding 46.14M
Float 38.4M


December 15, 2016 - By Richard Conner · 0 Comments

Notable Reporting: Pain Therapeutics Inc (NASDAQ TIE) Institutional Investor Sentiment Is 0.82
Sentiment for Pain Therapeutics Inc (NASDAQ TIE)

Pain Therapeutics Inc (NASDAQ TIE) institutional sentiment decreased to 0.82 in Q3 2016. Its down -0.49, from 1.31 in 2016Q2. The ratio worsened, as 14 investment managers increased or opened new equity positions, while 17 sold and decreased their holdings in Pain Therapeutics Inc. The investment managers in our partner’s database now have: 20.80 million shares , down from 22.53 million shares in 2016Q2 . Also, the number of investment managers holding Pain Therapeutics Inc in their top 10 equity positions was flat from 0 to 0 for the same number . Sold All: 6 Reduced: 11 Increased: 8 New Position: 6.

Pain Therapeutics, Inc. is a biopharmaceutical company. The company has a market cap of $27.23 million. The Firm is focused on drug development efforts on disorders of the nervous system, such as chronic pain. It currently has negative earnings. The Company’s lead drug candidate, REMOXY, is an abuse-deterrent, oral formulation of oxycodone .

About 129,006 shares traded hands. Pain Therapeutics, Inc. (NASDAQ TIE) has declined 75.21% since May 12, 2016 and is downtrending. It has underperformed by 84.37% the S&P500.

Analysts await Pain Therapeutics, Inc. (NASDAQ TIE) to report earnings on March, 7.

According to Zacks Investment Research, “Pain Therapeutics is developing a new generation of opioid painkillers. Opioids are drugs derived from the poppy plant. The company uses technology to reformulate opioid drugs, such as morphine, into new painkillers with improved clinical benefits. The company has four opioid painkillers in Phase II clinical trials. The company believes its drugs offer enhanced pain relief, fewer adverse side effects and reduced tolerance and addiction compared to existing opioid painkillers.”

Nantahala Capital Management Llc holds 0.47% of its portfolio in Pain Therapeutics, Inc. for 3.87 million shares. Bvf Inc Il owns 2.28 million shares or 0.43% of their US portfolio. Moreover, 683 Capital Management Llc has 0.05% invested in the company for 457,969 shares. The California-based David R. Rahn & Associates Inc. has invested 0.03% in the stock. Gagnon Securities Llc, a New York-based fund reported 69,466 shares.#img1#

PTIE Company Profile

Pain Therapeutics, Inc., incorporated on May 4, 1998, is a biopharmaceutical firm that develops drugs. The Firm is focused on drug development efforts on disorders of the nervous system, such as chronic pain. The Company’s lead drug candidate, REMOXY, is an abuse-deterrent, oral formulation of oxycodone (CII). The Company’s other products is FENROCK.

More recent Pain Therapeutics, Inc. (NASDAQ TIE) news were published by: Thestreet.com which released: “For Pain Therapeutics CEO, 3 FDA Rejections Are Worth $23 Million” on September 26, 2016. Also Marketwatch.com published the news titled: “Pain Therapeutics receives FDA letter saying NDA for opioid analgesic can’t be …” on September 26, 2016. Zacks.com‘s news article titled: “Pain Therapeutics (PTIE) Down on CRL for Chronic Pain Drug” with publication date: September 28, 2016 was also an interesting one.

Pain Therapeutics Inc.-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

California's Insurance Shake-up: What It Means

Updated Category News Views 0

There are plenty of rules in life that seem useless until suddenly they're not. California just passed a few fresh ones aiming to rein in the insurance sector. Zap your attention over to three new bills targeting fair insurance payouts and boosting coverage availability. It's a gust of wind in a typically frustrating insurance landscape, especially for the folks who've...

Continue Reading
Backroads Sets 2027 Egypt Tour with Active Adventures

Updated Category News Views 1

Backroads Brings Adventure Travel to Egypt in 2027 There's an entirely fresh way to get your kicks by the pyramids, and it's coming straight from Backroads, the bigwig of active travel. They're rolling out a Multi-Adventure Tour in the heart of Egypt for 2027. It's got all the bells and whistles: hiking, biking, and kayaking, packaged with a side of luxury at posh hotels...

Continue Reading
ECARX Leverages AI for Next-Gen Auto Intelligence

Updated Category News Views 3

ECARX's Latest Ventures in AI-Driven Mobility ECARX is making waves with its recent announcement to integrate Tencent Cloud's WorkBuddy AI with the Flyme AIOS operating system. It's not a small tweak; it's a big leap forward in pushing AI boundaries in automobiles. If you're looking at ECARX Holdings Inc. (Nasdaq: ECX) as an investment, here's the meat and potatoes of...

Continue Reading
Veteran Suicide Prevention: The Urgency Behind CVN's Push

Updated Category News Views 0

Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...

Continue Reading
Hivelocity's Outlet Store Slashes Server Wait Times

Updated Category News Views 0

Hivelocity Throws A Lifeline Amid Supply Chain Bottlenecks You ever tried getting your hands on the latest tech gadget only to find it's back-ordered till next Christmas? Well, that's the headache Hivelocity is sidestepping for customers with their new Outlet Store. By giving a big, hearty shrug to long hardware wait times, they're offering fully functional dedicated...

Continue Reading
Battling Razor Bumps: Breaking a Persistent Cycle

Updated Category News Views 3

Understanding Razor Bumps: More Than a Cosmetic Annoyance Crossing Great Neck this morning, I stumbled across a curious release from Laser by Aleya. Apparently, the problem with those pesky razor bumps plaguing many isn't just skin-deep. For some, especially those with coarse or curly hair, each razor stroke starts a relentless cycle of irritation that's as grinding as...

Continue Reading
Geron Faces Legal Woes: Investors Watch for Fallout

Updated Category News Views 1

Legal Storm Brewing Around Geron Corporation Ah, the familiar smell of trouble in corporate paradise, and this time it's drifting from Geron Corporation (NASDAQ: GERN). If you've got your chips on the table with these guys, you'd better pony up and listen up. Kuehn Law, PLLC is lighting a fire under Geron's board, snooping on whether their head honchos scuttled their...

Continue Reading
G20's Bold Move: Main Street Meets Wall Street

Updated Category News Views 1

An Unexpected Invitation to the Elite Table You'd think a community bank from Oklahoma crashing a party of international finance heavyweights sounds odd, but that's exactly how the G20 threw down this year. Holding the reins, the U.S. took a swing at something different. Secretary of the Treasury Scott Bessent rolled out the red carpet for private-sector leaders,...

Continue Reading
RealityMine Appoints CPO Amidst Strong Growth Momentum

Updated Category News Views 0

Pushing the Boundaries of Behavioral Data When a company like RealityMine posts a whopping 75% year-over-year revenue bump, you know they're not here to mess around. Enter Soumya Bijjal, a seasoned pro stepping in as their inaugural Chief Product Officer. This isn't just about adding to the C-suite boys' club; it's about locking in on a goldmine of behavioral data that's...

Continue Reading
Cost of Living Tops Financial Worries in 2026

Updated Category News Views 6

Financial Stress — The Silent Productivity Killer Down in the trenches of nine-to-five, it’s money that keeps stealing workers' peace of mind. The TELUS Mental Health Index shines a glaring spotlight on this, revealing that 58% of U.S. workers are most stressed by living costs. Now, that's a kicker when stacking it next to retirement or emergency savings. Those take...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Back Pain: The Discseel Procedure's Breakthrough

Updated Category News Views 237

Transforming Back Pain Treatments: The Impact of Discseel Procedure The Discseel Procedure is a groundbreaking outpatient treatment designed for those suffering from chronic back pain. This innovative solution not only allows for a swift return to regular activities—often as soon as the following day—but also offers a less invasive alternative to traditional spine...

Continue Reading
Garrett Moran Elected as New Chair for Year Up United Board

Updated Category News Views 199

Garrett Moran Steps Into Role as Year Up United Board Chair Year Up United has appointed Garrett Moran as its new Chairman of the Board. This transition comes after Paul Edgerley's impactful three-year term as Chair. Moran's extensive background in workforce development and strong ties with the organization make him an ideal fit for this vital role. Leadership Transition...

Continue Reading
Analyzing Spotify Technology's Significant Options Activity

Updated Category News Views 125

Spotify Technology's Options Activity Insights Recent trends in options trading have caught attention around Spotify Technology (NYSE: SPOT). An in-depth analysis reveals a noteworthy bearish inclination from some financial institutions, indicating potential market shifts ahead. A closer look at the options history for Spotify indicates that only 23% of traders maintain a...

Continue Reading
Day One Biopharmaceuticals: Future Prospects and Growth Potential

Updated Category News Views 76

Day One Biopharmaceuticals Boosts Market Prospects with Ojemda Recently, Day One Biopharmaceuticals (NASDAQ: DAWN) captured attention as analysts revised their price target upwards to $33 from $32, signaling a strong Buy rating. This optimistic shift stems from an insightful survey that revealed the growing adoption of Ojemda, their innovative treatment designed for...

Continue Reading
MicroAlgo Inc. Unveils Quantum Edge Detection for Image Processing

Updated Category News Views 295

MicroAlgo Inc. Introduces Quantum Edge Detection Algorithm MicroAlgo Inc. (NASDAQ: MLGO) has made significant advancements with its groundbreaking quantum edge detection algorithm, pushing beyond the boundaries set by traditional techniques. This algorithm is designed to enhance real-time image processing and cater to the emerging demands of edge intelligence devices....

Continue Reading